Tevogen Bio Holdings(DE:G280)
€5.010.00 (0.00%)
DE:G280
Tevogen Bio Holdings earnings date
€5.01
At close:0.00 (0.00%)
Tevogen Bio Holdings (G280) Q2 2026 Earnings Report
2 Followers
DE:G280 Q2 2026 EPS Results
- Actual EPS
- -EUR 1.39
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 1.36
DE:G280 Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- TBA
- Conference Call
- Thursday, August 13, 2026
DE:G280 Upcoming Earnings
Tevogen Bio Holdings's next earnings date is estimated for November 24, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:G280 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 24, 2026 | 2026 (Q3) | ―-1.60 | -1.36 | -17.07% (-0.23) | ― |
| Aug 13, 2026 | 2026 (Q2) | ―-1.39 | -1.36 | -1.67% (-0.02) | |
| Jun 03, 2026 | 2026 (Q1) | -2.40-1.47 | -2.96 | 50.48% (+1.49) | |
| Nov 14, 2025 | 2025 (Q3) | -2.77-1.36 | -0.03 | -4185.71% (-1.33) | |
| Aug 14, 2025 | 2025 (Q2) | -0.05-0.03 | -0.04 | 20.51% (+0.01) | |
| May 28, 2025 | 2024 (Q4) | -2.21-2.96 | -0.24 | -1151.92% (-2.72) | |
| Nov 19, 2024 | 2024 (Q3) | ―-1.58 | -0.8 | -97.05% (-0.78) | |
| Aug 15, 2024 | 2024 (Q2) | ―-1.79 | -0.56 | -219.81% (-1.23) | |
| May 29, 2024 | 2024 (Q1) | ―-0.24 | 2.01 | -111.76% (-2.25) | |
| May 01, 2024 | 2023 (Q4) | ―-11.83 | 2.01 | -688.69% (-13.84) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

